105 related articles for article (PubMed ID: 22572579)
1. Thieno[3,2-b]thiophene-2-carboxylic acid derivatives as GPR35 agonists.
Deng H; Hu J; Hu H; He M; Fang Y
Bioorg Med Chem Lett; 2012 Jun; 22(12):4148-52. PubMed ID: 22572579
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists.
Deng H; Hu H; He M; Hu J; Niu W; Ferrie AM; Fang Y
J Med Chem; 2011 Oct; 54(20):7385-96. PubMed ID: 21950657
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
4. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.
Shukla AK; Violin JD; Whalen EJ; Gesty-Palmer D; Shenoy SK; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9988-93. PubMed ID: 18621717
[TBL] [Abstract][Full Text] [Related]
5. Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα₁₃ and β-arrestin-2.
Jenkins L; Alvarez-Curto E; Campbell K; de Munnik S; Canals M; Schlyer S; Milligan G
Br J Pharmacol; 2011 Feb; 162(3):733-48. PubMed ID: 20958291
[TBL] [Abstract][Full Text] [Related]
6. Label-Free Cell Phenotypic Identification of D-Luciferin as an Agonist for GPR35.
Hu H; Deng H; Fang Y
Methods Mol Biol; 2016; 1461():3-17. PubMed ID: 27424891
[TBL] [Abstract][Full Text] [Related]
7. High-throughput identification and characterization of novel, species-selective GPR35 agonists.
Neetoo-Isseljee Z; MacKenzie AE; Southern C; Jerman J; McIver EG; Harries N; Taylor DL; Milligan G
J Pharmacol Exp Ther; 2013 Mar; 344(3):568-78. PubMed ID: 23262279
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of GPR35 display high species ortholog selectivity and varying modes of action.
Jenkins L; Harries N; Lappin JE; MacKenzie AE; Neetoo-Isseljee Z; Southern C; McIver EG; Nicklin SA; Taylor DL; Milligan G
J Pharmacol Exp Ther; 2012 Dec; 343(3):683-95. PubMed ID: 22967846
[TBL] [Abstract][Full Text] [Related]
9. Tyrphostin analogs are GPR35 agonists.
Deng H; Hu H; Fang Y
FEBS Lett; 2011 Jun; 585(12):1957-62. PubMed ID: 21601572
[TBL] [Abstract][Full Text] [Related]
10. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.
Zhao P; Sharir H; Kapur A; Cowan A; Geller EB; Adler MW; Seltzman HH; Reggio PH; Heynen-Genel S; Sauer M; Chung TD; Bai Y; Chen W; Caron MG; Barak LS; Abood ME
Mol Pharmacol; 2010 Oct; 78(4):560-8. PubMed ID: 20826425
[TBL] [Abstract][Full Text] [Related]
11. 8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.
Funke M; Thimm D; Schiedel AC; Müller CE
J Med Chem; 2013 Jun; 56(12):5182-97. PubMed ID: 23713606
[TBL] [Abstract][Full Text] [Related]
12. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
13. Beta-arrestin-biased ligands at seven-transmembrane receptors.
Violin JD; Lefkowitz RJ
Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory gallic Acid and wedelolactone are G protein-coupled receptor-35 agonists.
Deng H; Fang Y
Pharmacology; 2012; 89(3-4):211-9. PubMed ID: 22488351
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
[TBL] [Abstract][Full Text] [Related]
16. Use of the BRET 7TM receptor/beta-arrestin assay in drug discovery and screening.
Heding A
Expert Rev Mol Diagn; 2004 May; 4(3):403-11. PubMed ID: 15137906
[TBL] [Abstract][Full Text] [Related]
17. Stalk-dependent and Stalk-independent Signaling by the Adhesion G Protein-coupled Receptors GPR56 (ADGRG1) and BAI1 (ADGRB1).
Kishore A; Purcell RH; Nassiri-Toosi Z; Hall RA
J Biol Chem; 2016 Feb; 291(7):3385-94. PubMed ID: 26710850
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput screening system for G-protein-coupled receptors using β-lactamase enzyme complementation technology.
ZHAO CK; YIN Q; LI SY
Acta Pharmacol Sin; 2010 Dec; 31(12):1618-24. PubMed ID: 21102483
[TBL] [Abstract][Full Text] [Related]
19. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
[TBL] [Abstract][Full Text] [Related]
20. Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.
Jorgensen R; Martini L; Schwartz TW; Elling CE
Mol Endocrinol; 2005 Mar; 19(3):812-23. PubMed ID: 15528268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
